RVMD position history
The shares of Revolution Medicines (RVMD) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 2,750,000 shares, $76M, 0.38% of portfolio
- 2021 Q4: 2,750,000 shares, $69M, 0.37% of portfolio
- 2022 Q1: 3,250,000 shares, $83M, 0.44% of portfolio, Add +18.2%
- 2022 Q2: 3,250,000 shares, $63M, 0.39% of portfolio
- 2022 Q3: 2,500,000 shares, $49M, 0.29% of portfolio, Reduce −23.1%
- 2022 Q4: 1,698,015 shares, $40M, 0.27% of portfolio, Reduce −32.1%
- 2023 Q1: 3,283,600 shares, $71M, 0.40% of portfolio, Add +93.4%
- 2023 Q2: 2,783,480 shares, $74M, 0.42% of portfolio, Reduce −15.2%
- 2023 Q3: 3,325,480 shares, $92M, 0.46% of portfolio, Add +19.5%
- 2023 Q4: 6,736,854 shares, $193M, 0.96% of portfolio, Add +102.6%
- 2024 Q1: 15,015,744 shares, $484M, 2.2% of portfolio, Add +122.9%
- 2024 Q2: 9,757,692 shares, $379M, 1.8% of portfolio, Reduce −35.0%
- 2024 Q3: 11,317,692 shares, $513M, 2.5% of portfolio, Add +16.0%
- 2024 Q4: 13,248,692 shares, $579M, 2.9% of portfolio, Add +17.1%
- 2025 Q1: 13,534,692 shares, $479M, 2.7% of portfolio, Add +2.2%
- 2025 Q2: 14,325,692 shares, $527M, 2.3% of portfolio, Add +5.8%
- 2025 Q3: 29,251,384 shares, $1.4B, 5.6% of portfolio, Add +104.2%
- 2025 Q4: 14,582,796 shares, $1.2B, 5.5% of portfolio, Reduce −50.1%
- 2026 Q1: 13,604,796 shares, $1.3B, 7.5% of portfolio, Reduce −6.7%
- 2026 Q2: 13,550,796 shares, $2.5B, 11.7% of portfolio, Reduce −0.4%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|